Abbott Laboratories - AP30

Abbott Laboratories is a global, broad-based health care company devoted to the discovery, development, manufacturing, and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. Founded in 1888, the company employs more than 60,000 people, and markets its products in over 100 countries. The firm offers a wide range of specialized medicines, medical diagnostic instruments and tests, minimally invasive surgical devices, nutritional supplements for infants, children and adults, and products for veterinary care. It provides products for various diseases, such as hypertension and high blood pressure, infections, migraines, obesity, pain, secondary hyperparathyroidism, thyroid, urology and prostate, and arthritis. Miles D. White has been the chief executive officer of Abbott Laboratories for more than seven years. He has been with the pharmaceutical and biotechnology company for over 21 years. White earned a BS degree and MBA from Stanford University. The company is listed on the New York, Chicago, Pacific, London and Swiss stock exchanges. It is also traded on the Boston, Cincinnati and Philadelphia exchanges. Abbott Laboratories is headquartered in Abbott Park, Ill.

Abbott Laboratories is a global healthcare company that focuses on the development and manufacturing of a wide range of pharmaceuticals, medical devices, and nutritional products. With a commitment to improving health outcomes, Abbott Laboratories strives to provide innovative solutions that address the evolving needs of patients and healthcare professionals worldwide. Generated from their business information